Forum Replies Created
|
RE: Scope Management: Balancing Innovation and Constraints It's fine to consider some innovation, as long you can differentiate something the project truly needs and is worth the potential extra time and resources to enact this change. In my experience workin... |
In forum Intro to Project Management |
10 months ago |
|
RE: When Does It Makes Sense To Give Up On A Project? I agree with having feasibility check at the initiation phase of the project. However, to add to that, maybe it would be good practice to hold a risk assessment meeting and come up with a certain cond... |
In forum Intro to Project Management |
10 months ago |
|
RE: Managing Team Opinions While Sticking to Decisions Depending on the severity of the disagreement, it can be helpful to the team if you also bring an outside perspective, specifically someone who has faced an issue similar to the one causing the disagr... |
In forum Intro to Project Management |
10 months ago |
|
RE: Thoughts on BME degree, "a little of everything" I actually see the jack of all trades aspect of BME having some positive outcomes in my own experience. For me specifically, I wanted to focus on data analysis focus jobs, but because I also had exper... |
10 months ago | |
|
RE: Experience vs Education I'd lean more toward more co-ops or longer internships, due to the multiple years of experience employer often expect for a lot of jobs. For students, co-op can give the student the required experienc... |
10 months ago | |
|
RE: Academia vs. Industry: Why I Prefer Industry I also see myself drawn to industry. For me, it's mostly because I feel more comfortable dealing with a defined problem with a set deadline rather than the more open-ended approach. I've noticed that ... |
10 months ago | |
|
RE: Early Risk Management in a Project To make the team aware of risk on even smaller, simpler projects, you could incorporate short "Risk Sprints" in regular intervals of the planning cycle. In each of these meetings, the team will look f... |
1 year ago | |
|
RE: Contingency Planning One way of convincing management to invest in more contingency planning is to remind them that it is a regulatory and compliance risk. If the primary supplier cannot meet quality standards post its ap... |
1 year ago | |
|
RE: The Manager’s Role in Sustaining Team Engagement During Trials For long-running clinical trials, there are many ways to maintain engagement and motivation among team members. One way is to celebrate small milestones, like completing a trial phase. Showing appreci... |
1 year ago | |
|
RE: Creating Realistic Schedules in Clinical Trials One obstacle that can complicate timeline planning for large scale clinical trials is the variability added by conducting trials across multiple countries. Global trials come with more complexity that... |
1 year ago | |
|
RE: Dealing with Low Performers in Research Teams Without Losing Morale The first step should be to identify why the underperformance is happening, which can lead to visits to monitor process or talking to the team themselves to find the root cause. Then the necessary cha... |
1 year ago | |
|
RE: Keeping Clinical Research Teams Motivated During Long Timelines One strategy that can be used for keeping clinical research teams motivated is to create and celebrate short-term wins. It was mentioned in this week's slides that one motivator for people is team bas... |
1 year ago | |
|
RE: Cost Estimating – Choosing Between Speed and Accuracy @ms3548 I think the way to managing the transition from broad to bottom-up estimating is to treat it as a planned-hand off. For example, scheduling a formal review point once enough detail is availabl... |
In forum Project Management Knowledge Areas |
1 year ago |
|
RE: Scope Management and the Role of the WBS in Project Clarity In addition to balancing detail and simplicity for the WBS, I think it's also important the WBS structure has clear traceability between work and regulatory paperwork, like design inputs, outputs, ver... |
In forum Project Management Knowledge Areas |
1 year ago |
|
RE: Allergan's BIOCELL Breast Implant Recall: A Case Study in Quality and Risk Management I agree that regulatory approval shouldn't be the end all be all for safety. There are multiple strategies that companies can and should take before a product hits the market. One such method is a Fai... |
In forum Project Management Knowledge Areas |
1 year ago |